Skip to main content
. 2018 Jul 20;125(12):1581–1589. doi: 10.1111/1471-0528.15388

Figure 1.

Figure 1

Kaplan–Meier curve for on‐treatment abnormal vaginal bleeding in women aged under 50 years in the Hokusai‐VTE trial treated with edoxaban or warfarin. The outcome includes both major abnormal vaginal bleeding and clinically relevant nonmajor abnormal vaginal bleeding. The blue line indicates treatment with edoxaban and the red line treatment with warfarin. Numbers in blue and red indicate women at risk during the study for edoxaban and warfarin, respectively.